https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/accounts-payable https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/accounts-payable-other-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/accounts-receivable https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/accrued-income-taxes-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/accrued-liabilities-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/accrued-professional-fees-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/accumulated-depreciation https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/accumulated-depreciation-excluding-capital-leased-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/acquisition-consideration-transferred https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/additional-paid-in-capital https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/advertising-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/aoci https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-allowance-for-credit-loss https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-amortized-cost-after-allowance-for-credit-loss https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-maturities-next-rolling-twelve-months-amortized-cost-basis https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-maturities-next-rolling-twelve-months-fair-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-maturities-rolling-year-two-through-five-amortized-cost-basis https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-maturities-rolling-year-two-through-five-fair-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-realized-gain https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-realized-loss https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-securities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-unrealized-loss-position https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-number-of-positions https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-unrealized-loss-position-less-than-12-months https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-unrealized-loss-position-less-than-12-months-loss https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-unrealized-loss-position-less-than-12-months-number-of-positions https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/available-for-sale-debt-unrealized-loss-position-number-of-positions https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/basic-shares https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/business-acquisition-percentage-of-voting-interests-acquired https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/capital-expenditures https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/capital-lease-obligations-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/capital-leases-balance-sheet-assets-by-major-class-net https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/capitalized-computer-software-accumulated-amortization https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/capitalized-computer-software-amortization https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/capitalized-computer-software-net https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/cash-and-equivalents https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/cash-and-restricted-cash https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/cash-flow-breakdown https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/common-stock-no-par-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/common-stock-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/comprehensive-income https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/construction-in-progress-gross https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/cost-of-goods-and-services-sold-amortization https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/cost-of-revenue https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/costs-and-expenses https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/cover-page-shares-outstanding https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/current-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/current-income-tax-expense-benefit https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/current-liabilities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/current-portion-of-long-term-debt https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-carrying-amount https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-issued https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-maturing-after-year-five https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-maturing-in-year-five https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-maturing-in-year-four https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-maturing-in-year-three https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-maturing-in-year-two https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-repaid https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-securities-realized-gain-loss https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-unamortized-discount https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/decrease-in-utb-is-reasonably-possible https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-finance-costs-net https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-income-tax-liabilities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-offering-costs https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-asset-interest-carryforward https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-asset-intra-entity-transfer-asset-other-than-inventory https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-gross https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-net https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-other https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-employee-bonuses https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/deferred-tax-liabilities-other https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/depreciation https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/depreciation-and-amortization https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/diluted-shares https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/dividends-common-stock https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/effective-tax-rate https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/employee-related-liabilities-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/eps https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/eps-basic https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/equity-method-investments https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/fair-value-inputs-probability-of-default https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-interest-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability-payments-due https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-principal-payments https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-right-of-use-asset-accumulated-amortization https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-right-of-use-asset-before-accumulated-amortization https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/financing-cash-flow https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/foreign-currency-transaction-loss-before-tax https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/foreign-pretax-income https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/form-d-stocks https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/gain-loss-on-sale-of-derivatives https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/general-and-administrative-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/gross-profit https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/income-tax https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/income-taxes-paid https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-inventories https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/insider-transactions-other https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/insider-transactions-preferred https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/insider-transactions-stock-options https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/insider-transactions-stock-options/sales https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/insider-transactions-stock-units https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/insider-transactions-warrants https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/interest-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/interest-expense-on-debt https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/interest-expense-other https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/interest-income-other https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/interest-paid https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/interest-paid-net https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/inventory https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/inventory-finished-goods https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/inventory-noncurrent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/inventory-raw-materials https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/inventory-work-in-process https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/investing-cash-flow https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/investment-income-interest-and-dividend https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/investment-income-investment-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/investment-income-net https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/lease-and-rental-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/lease-cost https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/level-3-liability-settlements https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/level-3-liability-transfers-net https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/long-term-debt https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/long-term-debt-fair-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/marketable-securities-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/minority-interest https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/minority-interest-ownership-percentage-by-noncontrolling-owners https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/net-cash-from https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/net-cash-from-financing-activities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/net-cash-from-investing-activities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/net-cash-from-operating-activities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/net-change-in-cash https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/net-income https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/notes-payable-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/notes-payable-related-parties-noncurrent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/number-of-operating-segments https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/number-of-reportable-segments https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/oci-net-of-tax https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-cash-flow https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-expenses https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-income https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-cost https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-liability https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-liability-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-2 https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/operating-loss-carryforwards https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/other-accrued-liabilities-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/other-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/other-current-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/other-income https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/other-noncash-income-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/other-noncurrent-liabilities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/other-nonoperating-income-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/other-prepaid-expense-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/paid-in-kind-interest https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/payments-for-tenant-improvements https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/payments-to-acquire-equity-method-investments https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/preferred-shares-facts https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/preferred-stock-no-par-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/preferred-stock-shares-authorized https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/preferred-stock-shares-issued https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/prepaid-expense-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/prepaid-insurance https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/prepaid-rent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/pretax-income https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/pretax-income-domestic https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-collection-of-notes-receivable https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-issuance-of-mandatory-redeemable-capital-securities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-notes-payable https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-stock-issued https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/profit-loss https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/property-plant-and-equipment-gross https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/property-plant-and-equipment-gross-excluding-capital-leased-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/property-plant-equipment https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/public-float https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/redeemable-noncontrolling-interest-equity-carrying-amount https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/repayments-of-notes-payable https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/repayments-of-related-party-debt https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/research-and-development https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/restricted-cash https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/restricted-cash-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/restricted-cash-noncurrent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/retained-earnings https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/revenue https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/sga-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/share-price https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/shareholders-equity https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/shares-authorized https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/shares-issued https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/shares-subject-to-mandatory-redemption-settlement-terms-amount-current https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/shares-subject-to-mandatory-redemption-settlement-terms-amount-noncurrent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/short-term-lease-cost https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-based-compensation https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-issued-new-shares-sold https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-exercisable-number https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-outstanding-number https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stock-split-ratio https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-percent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/temporary-equity-shares-issued-value-new-issues https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/total-assets https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/total-liabilities https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/total-liabilities-and-equity https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/total-long-term-debt https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/unrecognized-tax-benefits https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/utb-increase-from-foreign-currency-translation https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/variable-lease-cost https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/warrants-and-rights-outstanding https://stock.noler.com/us/stock/biohaven-pharmaceutical-holding-company-ltd/weighted-average-number-of-share-outstanding-basic-and-diluted